CMIC is honored to have been awarded and recognized for the various awards listed below.
These awards are a reflection of our team’s dedication to our clients, our employees and the pharmaceutical and healthcare industries.
These awards are a reflection of our team’s dedication to our clients, our employees and the pharmaceutical and healthcare industries.
CMIC Group is pleased to announce that it has been selected as the Winner for the 2024 Fierce CRO Awards, “Leadership in Regulatory Compliance” Award. This award recognizes CROs that demonstrate exemplary adherence to regulatory standards and guidelines, ensuring compliance and facilitating smooth regulatory submissions.
View the full report here: Fierce CRO Awards 2024 Report
This Award recognizes contract research organizations that provide full or specialist services to their clients and which have an office or other base (but not necessarily a head office) either in Japan or the Asia region, including Australia. Judging considered the quality and benefits of services and relationships built with clients and will pay particular attention to innovative patient trial recruitment strategies brought to the table.
https://www.citeline.com/en/awards/citelinejapanawards
Designed to acknowledge excellence in leadership, the winner of this award will be the executive who has exhibited exemplary leadership throughout the qualifying period (1 January 2022-30 June 2023). Also important to the judges will be the executive’s career achievements, influence within the industry and characteristics that make a good leader, such as decisive and clear strategy, team building and employee welfare.
This Award is to recognize contract research organizations or contract development and manufacturing organizations that provide full or specialist services to their clients and which have an office or other base (but not necessarily a head office) either in Japan or the Asia region, including Australia. Entrant companies must offer services in Japan, but the achievements listed in the entry form do not necessarily have to be trials or services/manufacturing conducted in Japan (for example, clinical trials conducted in China or Australia are also eligible).
Judging will consider the quality and benefits of services and relationships built with clients. For CROs, it will pay particular attention to innovative patient trial recruitment strategies brought to the table, while for CDMOs, novel, more efficient and/or lower cost production processes will be considered.
CMIC Group Finalist for “Best Contract Research Organization: Full-Service Providers” Scrip Awards 2023
This awards recognizes the company’s ability to:
- Exceed sponsor expectations
- Innovate in patient engagement and recruitment
- Commit to diversity and inclusion in clinical trials
- Use AI and RWE to evolve the clinical development process
This Award is to recognize CROs that provide full or specialist services to their clients and which have an office or other base either in Japan or the Asia region including Australia.
Award Criteria:
- Quality of services
- Relationships built with clients
- Innovative patient recruitment strategies
- Overall capabilities & strengths
- Results exceeding sponsor expectations
- Improving performance in areas such as quality of data, timelines and transparency
- Steps towards streamlining data collection & reporting
Award Criteria:
- Growth Strategy Excellence
- Implementation Excellence
- Brand Strength
- Product Quality
- Product Differentiation
- Technology Leverage
- Price/Performance Value
- Customer Purchase Experience
- Customer Ownership Experience
- Customer Service Experience
